Atherectomy Devices Market Size, Share And Company Overview

1
Atherectomy Devices Market, 2021 - 2027
Copyright Precision Business Insights
2
Market Overview
The global atherectomy devices market was valued
at USD 710 Million in 2020 and is anticipated to
grow at USD 1103 Million till 2027 recording a
CAGR of 6.5 during the forecast period
2021-2027. Atherectomy serves as a great
substitute to angioscopy, which is used for
coronary artery illness. Increase in the cases of
peripheral vascular illnesses across the globe is
one of the primary factors to drive the global
atherectomy devices market. In addition, the
report discusses the implications of COVID-19,
including the industry's initial response and
strategies for ensuring business continuity in
the coming years. View Detailed Report
Description
3
Market Segments
The global atherectomy devices market has been
fragmented based on 1. By Technology Orbital
Atherectomy, Rotational Atherectomy, Orbital
Atherectomy, Directional Atherectomy2. By
Indication Coronary Artery Disease, Peripheral
Artery disease3. By End User Hospitals,
Ambulatory surgical centres and Others4. By
Geography North America, Asia Pacific, Europe,
Middle East and Africa, Latin America Request
Sample Report
4
Key Players
Some of the major key players in the atherectomy
devices market areBoston Scientific
Corporation (U.S.) R. Bard, Inc. (U.S.) Abbott
Laboratories (U.S.) Koninklijke Philips N.V.
(Volcano Corporation) (Netherlands) Medtronic Plc
(U.S.) Cordis Corporation (Cardinal Health, Inc.)
(U.S.) Jude Medical, Inc. (U.S.) Terumo Medical
Corporation (TERUMO CORPORATION)
(Japan) Request Sample Report
5
Europe Office Precision Business Insights, Kemp
House, 152 160 City Road, London EC1V
2NX Asia-Pacific Office Precision Business
Insights, 202, RVS Sree Homes, Opp Bharat
Petroleum Pump,Khanamet Road, Hitech City,
Hyderabad, India 500084 Email sales_at_precisionbu
sinessinsights.com Toll Free 1-866-598-1553